A Study To Evaluate The Efficacy And Safety Of TNX-102 SL In Patients With Fibromyalgia
Clinical trial NCT04172831 · COMPLETED
Trial details
- NCT number
- NCT04172831
- Sponsor
- Tonix Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-12-09
- Primary completion
- 2020-10-29
- Enrollment
- 503
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.